Skip to content
Her Next Chapter

Energy & RecoveryEmerging Science

Scientists Are Investigating a New Way to Protect Your Cells as You Age

Deep inside nearly every cell in your body, tiny structures help produce the energy that keeps you moving, thinking, and living. Now scientists are discovering how these structures change with age — and whether protecting them could reshape the future of medicine.

By Natalie BrooksEnergy & Performance Writer

Published 6 min read

A woman holding a yoga pose on a mat in a bright, plant-filled living room

You know those mornings when you wake up feeling like you could use another three hours of sleep?

You make your coffee. Get through your morning routine. Maybe squeeze in a workout.

But by midafternoon, you're already looking forward to getting back into bed.

It's tempting to wonder whether your body simply produces less energy as you get older.

And while everyday fatigue has many possible causes, scientists are investigating something fascinating at a much smaller scale.

Deep inside your cells are tiny structures called mitochondria.

You've probably heard them described as the powerhouses of the cell.

It's a phrase most of us learned in high school biology and promptly forgot.

But researchers are discovering that mitochondria may play an important role in how our bodies age, recover, and maintain physical function.

And some of the latest research is exploring whether protecting these microscopic structures could lead to entirely new treatments.

Meet the tiny powerhouses keeping you alive

Imagine your body is a city.

Your muscles are the transportation system. Your brain is the communication center. Your heart keeps everything moving.

And scattered throughout this enormous city are thousands of tiny power plants.

Those are your mitochondria.

Their primary job is to help convert energy from the food you eat into a molecule called ATP.

ATP is essentially your cells' spendable energy.

Your muscles use it to contract.

Your heart uses it to beat.

Your brain depends on it to support countless cellular processes.

Without a steady supply, your cells couldn't perform the work required to keep you alive.

But mitochondria do much more than produce energy.

They also participate in calcium regulation, cellular communication, and the processes that help cells respond to stress.

And unlike the power plants in our imaginary city, mitochondria are constantly changing.

They can grow, divide, merge, and be recycled when they're no longer functioning properly.

It's a remarkably sophisticated system.

What happens to mitochondria as we age?

Here's where things become interesting.

Your mitochondria don't simply wear out on your 40th birthday.

Instead, researchers have found that several systems responsible for maintaining healthy mitochondria can become less efficient with age.

One of those systems is called mitochondrial quality control.

Think of it as your cells' maintenance department.

Healthy cells continually monitor their mitochondria, repair certain problems, and remove components that are too damaged to function properly.

A process called mitophagy helps recycle damaged mitochondria so cells can maintain a healthier working population.

But as we age, these maintenance systems can become disrupted.

That may contribute to changes in muscle function, metabolic regulation, and the body's ability to respond to physical stress.

A 2026 review published in Nature Metabolism examined how mitochondrial quality-control systems influence human aging and longevity.

The researchers highlighted connections between mitochondrial dysfunction, chronic disease, inflammation, and age-related changes in metabolism.

But there's an important distinction.

Scientists are still determining when mitochondrial changes contribute to aging and when they're consequences of other age-related processes.

And that makes developing effective treatments considerably more complicated.

Could scientists actually protect our cellular power plants?

This question has led researchers toward a new generation of experimental treatments.

One particularly interesting compound is called SS-31, also known as elamipretide.

Unlike medications that primarily influence appetite or blood glucose, elamipretide was developed to interact with mitochondria.

More specifically, it targets a molecule called cardiolipin.

Cardiolipin is a specialized fat found in the inner membrane of mitochondria.

That membrane contains much of the machinery involved in producing ATP.

Think of cardiolipin as part of the structural support that helps keep the power plant's equipment organized.

When that structure is disrupted, mitochondrial function can suffer.

Researchers developed elamipretide to interact with cardiolipin and potentially help stabilize the inner mitochondrial membrane.

Laboratory and animal studies have investigated whether this interaction can improve mitochondrial structure and energy-related processes.

The findings were promising enough to support clinical research.

And in September 2025, something significant happened.

A mitochondrial peptide received FDA approval

On September 19, 2025, the FDA granted accelerated approval to elamipretide, marketed as Forzinity.

It became the first approved treatment for Barth syndrome, a rare genetic disease involving mitochondrial dysfunction.

Barth syndrome can cause serious heart problems, muscle weakness, fatigue, and exercise intolerance.

The approval was based on evidence of improved knee-extensor muscle strength in patients weighing at least 30 kilograms.

The FDA considered that improvement reasonably likely to predict meaningful clinical benefits.

However, the initial randomized trial had not demonstrated statistically significant improvements in its primary walking-distance and fatigue outcomes.

That's why the approval was granted through the accelerated pathway, with an additional confirmatory trial required.

Still, the decision marked an important development.

It showed that a treatment designed around mitochondrial biology could reach clinical approval for a specific disease.

And it gave researchers another reason to continue investigating mitochondria-targeted medicines.

Does that mean SS-31 could slow aging?

This is where we need to separate excitement from evidence.

That doesn't mean it has been proven to increase energy in otherwise healthy adults, improve everyday workout recovery, or extend human lifespan.

Scientists have investigated elamipretide and other mitochondria-targeted approaches in additional conditions, but the evidence remains mixed or incomplete.

And research on a disease involving severe mitochondrial dysfunction doesn't automatically tell us what would happen in a healthy 38-year-old woman.

There are also safety considerations, including injection-site reactions and other possible adverse events.

For now, the broader anti-aging applications remain research questions.

What can you actually do for your mitochondria today?

Here's the encouraging part.

You don't need an experimental treatment to influence mitochondrial health.

One of the best-studied ways to support mitochondrial function is something you've probably been encouraged to do for years.

Exercise.

When you challenge your body through physical activity, your cells respond.

They adapt to the increased demand for energy.

And part of that adaptation involves changes in mitochondrial function and organization.

A comprehensive 2025 review in the Annual Review of Physiology examined how exercise influences mitochondrial adaptations.

The researchers described physical activity as a powerful stimulus capable of changing mitochondrial biology.

Aerobic exercise can improve the ability of working muscles to use oxygen and sustain activity.

Resistance training supports muscle strength and can also influence mitochondrial characteristics.

You don't need to train for a marathon.

Walking, cycling, swimming, and strength training can all contribute to a physically active lifestyle.

The most useful routine is one you can perform consistently and gradually adapt to your abilities.

Adequate nutrition, sleep, and recovery help support the broader systems your body depends on, too.

And if persistent fatigue is interfering with your daily life, it's worth discussing with a healthcare professional. Conditions such as anemia, thyroid disorders, sleep problems, and other medical issues can cause fatigue.

Everyday tiredness isn't a reliable way to diagnose mitochondrial dysfunction.

The future of energy research is getting interesting

For decades, mitochondria were primarily discussed as structures that produce energy.

Now scientists are recognizing how deeply they're involved in cellular maintenance, metabolism, and the biological processes associated with aging.

And that opens up fascinating possibilities.

Could future treatments help certain cells maintain healthier mitochondrial function?

Could researchers identify ways to preserve physical independence as people age?

Could understanding mitochondrial quality control lead to better treatments for metabolic or degenerative diseases?

These questions are being actively investigated.

The answers may take years, and some promising ideas won't translate into effective therapies.

But the scientific progress is worth watching.

Because understanding how our cells maintain and use energy may eventually help us understand how to preserve health and physical function for longer.

And that's a future worth being curious about.

Sources

The research behind this article

  1. Picca A, Ferrucci L. (2026). Mitochondrial Quality Control in Human Ageing and Longevity. Nature Metabolism. Read the review
  2. Exercise as Mitochondrial Medicine: How Does the Exercise Prescription Affect Mitochondrial Adaptations to Training? (2025). Annual Review of Physiology. Read the review
  3. U.S. Food and Drug Administration (September 19, 2025). FDA Grants Accelerated Approval to First Treatment for Barth Syndrome. Read the announcement
  4. U.S. Food and Drug Administration. Drug Trials Snapshot: Forzinity (elamipretide). Clinical trial findings, limitations, and patient characteristics. Read the trial summary
  5. Elamipretide: The First Cardiolipin-Directed Mitochondrial Therapeutic for Barth Syndrome Approved Under Accelerated Approval (2025). Review of the drug's development, clinical evidence, and remaining questions. Read the review

Editorial note: This article is intended for educational purposes and does not replace individualized medical advice. Elamipretide is approved only for a specific indication and has not been established as a treatment for general fatigue, healthy aging, or longevity.

  • mitochondria
  • energy
  • exercise
  • elamipretide
A woman doing a dumbbell squat in a sunlit home workout roomFree guide

The 8-Week Plan to Lose Body Fat After 35 — And Keep It Off

A science-backed approach to sustainable fat loss for women over 35.

  • Build a leaner, stronger, more defined body.
  • Break the cycle of losing and regaining weight.
  • Feel strong, confident, and at home in your body.
  • Learn an adaptable system you can use toward a longer-term goal.

You'll also receive The Next Chapter Letter. Unsubscribe anytime. Individual results vary. This guide is educational and not medical advice.

Energy & Recovery

Still Sore Days After a Workout? Your Age Might Not Be the Reason.

Remember when you could push through a tough workout and feel perfectly fine the next morning? If recovery feels different in your 30s and 40s, researchers have some interesting explanations — and a few surprisingly simple solutions.

7 min read